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Abstract
Peroxynitrite was demonstrated to inhibit the active efflux of glutathione S-conjugates 2,4-dinitrophenyl-S-glutathione
.and bimane-S-glutathione from human erythrocytes and the erythrocyte membrane ATPase activity stimulated by
 .glutathione S-conjugates. As the multidrug resistance-associated protein MRP is responsible for the transport of
glutathione S-conjugates in mammalian cells, these results point to the possibility of the effect of peroxynitrite on the MRP
function.
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1. Introduction
  ..Peroxynitrite oxoperoxonitrate -1 , formed in the
reaction between nitric oxide and superoxide is
thought to be the main agent responsible for nitric
oxide toxicity. It is believed to contribute to the
w xbactericidal action of the phagocytes 1,2 and be the
major compound responsible for the ischaemia-reper-
w xfusion injury 3–5 and tissue damage by inflamma-
w xtion 6–8 . Peroxynitrite is known to damage nucleic
w x w xacids 9,10 and proteins 11–13 , and to induce lipid
w xperoxidation 14,15 . Nitration of tyrosine residues by
peroxynitrite may disturb signal transduction path-
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ways, especially those involving tyrosine kinases
w x16,17 . Its low concentrations have apoptotic while
higher concentrations a necrotic action on mam-
w xmalian cells 18,19 . We found that the action of
peroxynitrite on the erythrocyte causes oxidation of
intracellular glutathione, peroxidation of membrane
lipids, aggregation and nitration of membrane pro-
teins and inactivation of acetylcholinsterase though
w xnot a significant hemolysis 20 .
Peroxynitrite affects also cellular transport pro-
cesses. This compound decreases the Naq transport
in rabbit alveolar type II cells by damaging apically
q w xlocated amiloride-sensitive Na channels 21 and
inhibits erythrocyte membrane Ca2q-ATPase, Mg2q-
q q w xATPase and Na rK -ATPases 20 and high affinity
glutamate transporters from rat brain reconstituted in
w xliposomes 22 . Peroxynitrite inhibits mitochondrial
w xrespiration 23 strongly depressing complex I- and
complex II-dependent mitochondrial oxygen con-
sumption and activities of succinate dehydrogenase
w xand mitochondrial ATPase 24 . Exposure of mito-
chondria to higher doses of peroxynitrite induces
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depolarisation and cyclosporin-A-sensitive calcium
w xefflux 25 .
The aim of the present paper was to examine the
effect of peroxynitrite on another important transport
process, extensively studied recently viz. the active
transport of glutathione S-conjugates.
2. Materials and methods
2.1. Materials
 .2,4-Dinitrophenol DNP , 1-chloro-2,4-dinitro-
 . X  .benzene CDNB , 5,5 -dithio-bis- 2-nitrobenzoic acid
 .  .DTNB , ouabain, adenosine-5-triphosphate ATP ,
 . X Xethylene glycol-bis b-amino ethyl ether -N,N,N ,N -
 .tetraacetic acid EGTA , ethylenediaminetetraacetatic
 .  .acid EDTA , reduced glutathione GSH , Malachite
 .Green and phenylmethylsulfonyl fluoride PMSF
 .were obtained from Sigma Deisenhofen, Germany .
 .Monochlorobimane mBCl was from Molecular
 .Probes Eugene, USA . 2,4-Dinitrophenyl-S-gluta-
 .thione DNP-SG was synthesized from CDNB and
w xglutathione non-enzymatically 26 . HBS cellulose
 .was from Serva Heidelberg, Germany . All other
 .chemicals were from POCh Poland and were of
analytical grade. All solutions were made with water
 .purified by the Milli-Q system Millipore having a
resistivity of 18.4 MV cmy2.
Fresh human blood were obtained from blood of
healthy donors anticoagulated with citrate. Erythro-
cytes were isolated by centrifugation at 48C, 2000=g
and purified by three cycles of resuspension and
washing with 20 volumes of phosphate-buffered saline
 .PBS containing 1 mM ethylenediaminetetraacetate
 .EDTA and 0.5 mM phenylmethylsulfonyl fluoride
 .PMSF . After careful removal of the buffy coat,
residual leukocytes were removed by passing erythro-
cyte suspensions through a column of HBS cellulose.
Erythrocyte ghosts for determination of ATPase ac-
tivity were prepared from washed cells according to a
w xmodification of the method of Dodge et al. 27 .
Briefly, erythrocytes were hemolysed on ice with 20
 .volumes of 20 mM borate buffer pH 7.6 , containing
1 mM EDTA and 0.5 mM PMSF as proteolytic
inhibitors, and centrifuged for 20 min at 48C at
20 000=g. The ghosts were resuspended in ice-cold
 .5 mM borate buffer pH 7.6 and 0.1 mM EDTA, and
this process was continued until the ghosts were free
from residual hemoglobin.
2.2. Exposure of erythrocytes and erythrocyte ghosts
to peroxynitrite
Peroxynitrite was synthesized according to the
w xmethod of Pryor et al. 28 . This method provides
peroxynitrite of low ionic strength that does not
contain hydrogen peroxide as an impurity. Briefly, an
ozone stream from an ozonator 75 mgrml in oxy-
.gen, 100 mlrmin was bubbled through a glass-frit
into 100 ml of 0.1 M sodium azide in water pH
.adjusted previously to 12 with 1 N NaOH chilled to
08C in an ice-water mixture for about 60 min. An
ATO-3 medical ozonator Metrium-Krio, Warsaw,
.Poland was used. Peroxynitrite formation was moni-
tored spectrophotometrically during the synthesis and
the main sample was collected about 5 min after
obtaining the maximum concentration. So obtained
peroxynitrite solution contains about 1 mM sodium
w xazide 28 . The final concentration of peroxynitrite
was about 30–35 mM. Stock solutions were stored at
y258C and used within 3–4 weeks after synthesis.
Before each experiment the concentration of peroxy-
nitrite was estimated spectrophotometrically at 302
 .nm in 0.1 M NaOH e s1670 . Erythrocytes ob-M
tained as above at the hematocrits of 5, 10, 15 or
20% resuspended in appropriate buffer or preincu-
.bated with CDNB or monochlorobimane were treated
with peroxynitrite and examined for glutathione-S-
conjugate efflux or for GSH content. The highest
dose of peroxynitrite used did not affect the DNP-SG
absorbance and diminished the fluorescence of B-SG
by less than 10%. For the assay of glutathione S-con-
jugate-stimulated ATPase activity erythrocyte ghosts
 .protein concentration of 4 mgrml were treated with
peroxynitrite and enzymatic activity was estimated as
described below. To check for the potential effect of
the products of peroxynitrite decomposition, peroxy-
nitrite was allowed to decompose for 30 min in the
 .phosphate buffer pH 7.4 before the addition of
erythrocytes.
2.3. Measurement of the transport of glutathione-S-
conjugates
Transport of 2,4-dinitrophenyl-S-glutathione
 .DNP-SG was measured according to the procedure
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w xof Board et al. 29 . Washed erythrocytes were resus-
 .pended in phosphate-buffered saline PBS and incu-
bated with 1 mM CDNB for 15 min at 378C to form
2,4-dinitrophenyl-S-glutathione. Then the cells were
washed of excess CDNB at 08C and suspended at a
hematocrit of 20% in the transport buffer containing
138 mM NaCl, 5 mM KCl, 6.1 mM Na HPO , 1.42 4
mM NaH PO , 1 mM MgCl and 1 mgrml glucose2 4 2
 .pH 7.4 . Initial concentration of DNP-SG in so
treated cells was 1.65"0.16 mmolrl cells mean"
.S.D.; ns5 . The cell suspensions were then incu-
bated at 378C, treated with peroxynitrite and the
export of DNP-SG was quantified by withdrawal of
aliquots of the cell suspensions after ‘zero-time’
 .about 10 s , 10, 20 and 30 min, centrifugation and
estimation of absorbance of the conjugate at 340 nm
w xin the supernatants 29 . Hemolysis was negligible;
however, in order to exclude interference from ab-
sorbance by the released hemoglobin, the super-
natants were added with an equal amount of 10%
 .trichloroacetic acid TCA , centrifuged and ab-
sorbance of DNP-SG read in so obtained extracts. In
order to make a correction for DNP-SG released from
cells which hemolysed during the experiment, ab-
sorbance of the supernatants at 540 nm was read to
estimate per cent of hemolysis and the amount of
DNP-SG liberated with hemoglobin was calculated
on the basis of hemoglobin and DNP-SG content of
cells at time zero. The correction did not exceed 2%.
Transport of bimane-S-glutathione through ery-
throcyte membranes was made as described previ-
w xously 30 with some modifications. Briefly, human
erythrocytes at the hematocrit 50% in the transport
buffer were incubated for 5 min with 10 mM mBCl
final concentration, mBCl was added from a stock
.solution of 5 mM in ethanol at room temperature.
Then they were suspended at a hematocrit of 5% for
.some experiment of 10, 15 and 20% in the transport
buffer and incubated at 378C. Initial intracellular
concentration of B-SG was 14.7"2.8 mmolrl cells.
Aliquots of the suspensions were withdrawn after
zero-time, 3, 6, 9, 12 and 15 min, centrifuged and
supernatant was added with an equal volume of
ice-cold 10% TCA for hemoglobin removal. Hemoly-
sis was checked and it was always below 1%. Never-
theless, a correction of each fluorescence value for
BSG released by hemolysis based on the determina-
tion of the amount of released hemoglobin from
.absorbance at 540 nm was made. Fluorescence of
the supernatants were measured in a Perkin-Elmer
LS-5B fluorescence spectrophotometer at excitation
wavelength of 386 nm and emission wavelength of
w x476 nm 30 .
2.4. Determination of the glutathione S-conjugate
stimulated ATPase acti˝ity
ATPase activity was assayed as described else-
w xwhere 31 . Briefly, erythrocyte membranes were in-
cubated in the assay medium consisting of 100 mM
 .Tris-HCl pH 7.4 , containing 10 mM MgCl , 2 mM2
 2q .ATP, 1 mM EGTA to inhibit Ca -ATPase and 0.1
 q q .mM ouabain to inhibit Na rK -ATPase for 30 min
at 378C in the absence of other additives or in the
presence of 4 mM DNP-SG or 1 mM DNP. DNP was
demonstrated to stimulate the activity of glutathione
w xS-conjugate pump even better then DNP-SG 31,32 .
The differences in activities in the presence and in
the absence of the stimulators was referred to as the
DNP-SG-dependent and DNP-dependent ATPase ac-
tivities, respectively. The inorganic phosphate liber-
w xated was quantitated with Malachite Green 33 . Pro-
w xtein was measured according to Lowry et al. 34 .
2.5. GSH content
The concentration of GSH was determined by the
w xmethod of Ellman 35 . Briefly, 2-ml aliquots of
control and peroxynitrite-treated red cell suspensions
were added with 0.2 ml of 50% TCA and cen-
trifuged. To 1 ml of the supernatants 1 ml of 1 M
 .phosphate buffer pH 7.4 and 0.1 ml of the Ellman
 .reagent 1 mM were added. Concentration of GSH
was determined spectrophotometrically at 412 nm
using the absorption coefficient 13.6 mMy1 cmy1.
3. Results
Exposure of erythrocytes to peroxynitrite de-
creased the rate of extrusion of DNP-SG Fig. 1,
.  .Table 1 and B-SG Fig. 2, Table 2 . However, while
the time course of DNP-SG efflux showed a consid-
 .erable linearity Fig. 1 , that of B-SG efflux was not
linear. In control cells, the transport rate decreased in
time. Initial transport rate decreased in peroxynitrite-
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Table 1
  ..  .Rate of DNP-SG efflux nmolr mlPh from erythrocytes 20% hematocrit treated with peroxynitrite
Peroxynitrite concentration Control 300 mM 500 mM 700 mM 1 mM 1.5 mM
  ..DNP-SG efflux nmolr ml cellsPh 578.5"23.2 508.3"30.0 452.5"27.9 404.5"23.5 358.8"21.5 265.0"12.2
Mean"S.D., ns4.
Fig. 1. DNP-SG efflux from human erythrocytes in the absence
 .and in the presence of peroxynitrite 300 mM–1.5 mM . Erythro-
 .cytes 20% hematocrit , preloaded with CDNB were added with
peroxynitrite and incubated at 378C. Data presented as mean"
 .S.D. ns4 .
treated cells as a function of peroxynitrite concentra-
tion but the time-dependent decrease became progres-
sively smaller in cells treated with increasing doses
of peroxynitrite until in cell treated with the highest
doses there was a recovery-type increase in the trans-
 .port rate during incubation Fig. 2, Table 2 . There-
fore, initial transport rates measured during first 3
min of incubation were compared.
Peroxynitrite concentration needed for 50% inhibi-
tion of the rate of DNP-SG efflux was 1.31"0.22
mM while that for 50% inhibition of B-SG efflux
 .was 0.39"0.09 mM mean"S.D. . It cannot be
concluded on these basis that the B-SG transport is
more sensitive to peroxynitrite than the DNP-SG
transport since the transport of both substrates was
studied in cells exposed to peroxynitrite at different
 .hematocrits 20% and 5%, respectively . However,
comparison of c values for both compounds at the50%
same hematocrit values demonstrates that it is indeed
 .the case Table 3 .
We have demonstrated previously that peroxyni-
trite brings about a transient oxidation of erythrocyte
w xglutathione 20 . In this study we confirmed this
effect under conditions of measurement of B-SG
 .transport Table 4 . The recovery of reduced glu-
tathione observed upon incubation of peroxynitrite-
treated cells seemingly coincides with the time-de-
 .pendent increase of the B-SG extrusion rate Fig. 2
and apparently contributes to this effect.
Fig. 2. Bimane-S-glutathione efflux from human erythrocytes in
the absence and in the presence of peroxynitrite 300 mM–1.5
.mM . Erythrocytes, preincubated at 50% hematocrit with
monochlorobimane were suspended at a hematocrit of 5%, treated
 .with peroxynitrite and incubated at 378C. Mean"S.D. ns3–8 .
Table 2
  ..  .Initial rate of bimane-S-glutathione efflux nmolr mlPh from erythrocytes 5% hematocrit treated with peroxynitrite
Peroxynitrite concentration Control 100 mM 300 mM 500 mM 700 mM 1 mM
  ..B-SG efflux nmolr ml cellsPh 110.0"10.3 91.0"12.0 61.0"5.6 30.4"5.2 25.0"6.3 9.3"1.8
Mean"S.D., ns3–8.
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Table 3
Concentration of peroxynitrite inducing 50% inhibition of the
rate of DNP-SG and B-SG efflux from erythrocytes exposed at
various hematocrits
 .  .Hematocrit % c mM50%
DNP-SG B-SG
5 0.93"0.11 0.39"0.09
10 1.18"0.21 0.44"0.08
15 1.26"0.20 0.43"0.12
20 1.31"0.22 0.45"0.10
Mean"S.D., ns3.
The transport inhibition observed was due to the
action of peroxynitrite and not to impurities or de-
composition products contained in the peroxynitrite
preparations as exposure of erythrocytes to peroxyni-
trite solutions allowed to decompose for 15 min at
pH 7.4 did not bring about changes in the glutathione
S-conjugate transport higher than 10% of those seen
 .with solutions containing peroxynitrite not shown .
The activity of the high-affinity component of the
glutathione S-conjugate transport can also be moni-
tored in erythrocyte membrane by measurement of
the DNP-SG-stimulated Mg2q-ATPase activity of the
Table 4
Time course of GSH content of peroxynitrite-treated erythrocytes
 .Peroxynitrite GSH content %
 .mM 100 300 500 700
‘Zero-time’ 73.0"11.5 28.7"7.6 12.3"4.3 10.3"3.6
5 min 71.7"6.6 18.7"6.8 9.7"2.4 9.0"2.9
10 min 69.7"7.1 18.8"5.3 10.7"2.8 8.7"2.6
20 min 69.9"8.3 22.3"6.0 10.7"3.1 8.6"2.1
30 min 71.4"6.3 23.3"5.3 12.3"3.3 11.7"2.8
40 min 73.3"10.2 29.3"5.9 13.7"1.4 14.7"2.6
Hematocrit of the suspension: 5% GSH content of control cells
 .1.72"0.14 mmolrml cells assumed to be 100%. Mean"S.D.,
ns3.
w xmembranes 31,36 . This activity was inhibited in a
dose-dependent manner upon treatment of erythro-
 .cyte membranes with peroxynitrite Table 5 .
4. Discussion
Transport of glutathione S-conjugates is an impor-
tant element of xenobiotic detoxification, often re-
w xferred to as detoxification phase III 37 . The
‘glutathione S-conjugate pump’ plays apparently a
significant role in cellular defense under oxidative
 .stress conditions since i is able to transport glu-
tathione conjugates of lipid peroxidation products and
 . w xii extrudes oxidized glutathione 37,38 helping in
maintaining and restoration the proper redox state of
the cells.
Studies on the glutathione S-conjugate transport
across the human erythrocyte membrane pointed to
the existence of two kinetic components of the trans-
w xport 38–41 . The nature of this kinetic heterogeneity
of the transport is unclear and its elucidation requires
w xstructural studies 42 . Anyhow, measurements of the
DNP-SG efflux from erythrocytes given millimolar
concentrations of CDNB allow for characterization of
the low-affinity, high-capacity transport component
while monitoring the B-SG efflux from cells treated
with micromolar concentrations of monochlorobi-
mane provides an insight into the activity of the
high-affinity, low-capacity component.
The transport of both substrates studied was inhib-
ited by peroxynitrite, that of B-SG being more prone
to inhibition. As peroxynitrite affects various con-
stituents of the erythrocyte, several possibilities of
explanation of the effects observed should be consid-
 .ered: i peroxynitrite modulates the glutathione S-
 .conjugate pump itself, ii peroxynitrite induces lipid
peroxidation and this influences the pump activity,
Table 5
Effect of peroxynitrite on the basal Mg2q-ATPase and ATPase activity stimulated by DNP-SG and DNP
  ..Peroxynitrite ATPase activity nmol P r mg proteinPhi
Control 100 mM 300 mM 500 mM 1 mM
2q  .  .  .  .  .Mg -ATPase 239"34 s100% 172"8 72% 154"17 64% 144"23 60% 136"21 57%
 .  .  .  .  .DNP-SG-stimulatory activity 101"35 s100% 86"19 85% 58"22 57% 67"26 66% 56"23 32%
 .  .  .  .  .DNP-stimulatory activity 409"55 s100% 345"26 84% 290"37 71% 206"37 50% 122"25 33%
 .Erythrocyte ghosts 4 mg protein per ml were incubated with peroxynitrite. Mean"S.D., ns3.
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 .iii peroxynitrite causes oxidation of glutathione and
oxidized glutathione inhibits the glutathione S-con-
 .jugate pump, and iv peroxynitrite causes formation
of S-nitrosoglutathione which inhibits the pump.
Inhibition by peroxynitrite of the ATPase activity
stimulable by glutathione S-conjugates in isolated
 .  .membranes can be explained only by i or ii . These
two possibilities cannot be easily distinguished since
peroxynitrite induces lipid peroxidation in erythro-
w xcyte membranes 20 . However, we have observed
inhibition of erythrocyte glutathione S-conjugate
w xpump by organic peroxides 43 under conditions of
no detectable peroxidation of red cell membrane lipids
w x44 which demonstrates that these two events can
 .proceed independently. iii Oxidized glutathione in-
hibits competitively the high-affinity kinetic compo-
w xnent of the glutathione S-conjugate pump 38 but has
no effect on the low-affinity component of the pump
w x38,45 . Therefore, glutathione oxidation by peroxyni-
trite could contribute to the higher inhibition of the
B-SG transport as compared with DNP-SG transport
 .Table 3 and to the partial reversibility of the inhibi-
 .  .tion of B-SG transport Fig. 2 . iv Inhibition of the
glutathione S-conjugate pump by S-nitrosogluta-
thione formed by peroxynitrite does not seem to be a
significant factor as the main product of the interac-
tion of peroxynitrite with glutathione is oxidized
glutathione, S-nitrosoglutathione being formed in very
low amounts corresponding to about 1% of glu-
. w xtathione in endothelial cells 46 . Moreover, although
S-nitrosoglutathione inhibits glutathione reductase
w x47 , it seems to be a substrate for the glutathione
 .S-conjugate pump Rychlik et al., unpublished .
The concentrations of peroxynitrite used in this
study may appear unphysiologically high though the
highest local rates of peroxynitrite production were
w xestimated to be of an order of 1 mMrmin 48 .
However, it should be considered that, due to the
high decomposition rate of peroxynitrite at neutral
pH, exposure to a single dose of peroxynitrite is
equivalent to a prolonged exposure to a much lower
concentration of this compound. For example, the
exposure to a bolus of 250 mM peroxynitrite is
equivalent to the exposure to a steady-state concen-
w xtration of only 1 mM peroxynitrite for 7 min 49 .
The data presented demonstrate that the ‘gluta-
thione S-conjugate pump’ can be one of the cellular
targets for peroxynitrite. The molecular identity of
the ‘glutathione S-conjugate pump’ has been a matter
of controversy. Recent findings identify it with the
 . wmultidrug resistance-associated protein MRP 50–
x w x52 , present also in the erythrocyte 53 though a
 .related protein, canalicular MRP cMRP or canalicu-
 .lar multispecific organic anion transporter cMOAT
has been found in the canalicular membranes of
w xhepatocytes 54,55 .
Therefore, the present data indicate that peroxyni-
trite can inhibit MRP, a transporter involved in the
removal of xenobiotics and oxidized glutathione from
various cells and in the removal of chemotherapeutics
from malignant cells. This phenomenon may potenti-
ate the cellular effects of oxidative stress but, on the
other hand, can contribute to the role of nitric oxide
in the host-tumor interactions.
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